PolarityTE Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Total Funding:$17.8M
Industry:Biotech
Founded:N/A
Lead Investor(s):Cantor Fitzgerald
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • PolarityTE's estimated annual revenue is currently $1.6M per year.
  • PolarityTE received $17.8M in venture funding in September 2017.
  • PolarityTE's estimated revenue per employee is $12,917
  • PolarityTE's total funding is $17.8M.

Employee Data

  • PolarityTE has 121 Employees.
  • PolarityTE grew their employee count by -21% last year.
  • PolarityTE currently has 4 job openings.

Executive Contacts

NameTitleEmail
Kolby DaySvp Operations
Marc SconzoArea Sales Director East
Stephen MilnerChief Clinical Officer
Jacob PattersonVice President Of Finance
Brett VanWagonerSenior Director Of CybersecurityEmail Available
Jeff DeVincentSenior Territory Manager
Philip StoneDirector Of Information Technology
Eric ChanDirector of Proteomics
Nick ElvisRegional Sales Director
Anshu GuptaSr Territory Manager

PolarityTE (NASDAQ: COOL) is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patient's own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient's own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient's own tissue and uses the patient's own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.

keywords:N/A

121

Number of Employees

$1.6M

Revenue (est)

4

Current Jobs

-21%

Employee Growth %

$17.8M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
PolarityTE
$1.6M121-21%N/A
Predictive Biot...
$10.2M6627%N/A
Myriad Genetics...
N/A2212N/AN/A
ZYTO
$8.7M568%N/A
Scientific Comp...
$6.4M41-20%N/A
Carterra
$9.9M6421%N/A
Missing a competitor? Contribute!?
Submit

PolarityTE News

09/09/2019 - SkinTE Data to be Presented at the American Society of ...

SALT LAKE CITY, Sept. 9, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...

08/16/2019 - PolarityTE to Present at Military Health System Research ...

SALT LAKE CITY, Aug. 16, 2019 /PRNewswire/ -- PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing and commercializing ...

08/28/2019 - PolarityTE to Attend HC Wainwright 21st Annual Healthcare ...

SALT LAKE CITY, Aug. 28, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...

PolarityTE Funding

DateAmountRoundLead InvestorsReference
2017-09-22$17.8MUndisclosedCantor FitzgeraldArticle

PolarityTE Executive Hires

DateNameTitleReference
2017-03-01Burke PowersVice President of Product DevelopmentArticle
2017-10-09Maurice NahabedianChief Surgical OfficerArticle
2018-09-27Alain AdamVice President, SalesArticle
2018-10-22Sharon WhalenVice President of Market AccessArticle
2018-11-28Matt KempChief Commercial OfficerArticle
2019-01-08Jon BurrowsPres Contract Services/SVP Corporate DevelopmentArticle
2019-01-30David SeaburgPresident of Corporate DevelopmentArticle
2019-04-01Richard HagueCOOArticle